Single cell proteogenomic analysis of aberrant monocytosis in TET2 mutant premalignant and malignant hematopoiesis
暂无分享,去创建一个
N. Chia | T. Lasho | M. Timm | C. Finke | N. Gangat | H. Olteanu | K. Reichard | A. Mangaonkar | M. Binder | R. Ketterling | Zhuoer Xie | A. Tefferi | Jenna A. Fernandez | M. Patnaik | A. Gaspar-Maia
[1] A. Tefferi,et al. Clonal compositions involving epigenetic regulator and splicing mutations in CHIP, CCUS, MDS, and CMML. , 2022, Leukemia research.
[2] Julie G. Burel,et al. The Challenge of Distinguishing Cell–Cell Complexes from Singlet Cells in Non‐Imaging Flow Cytometry and Single‐Cell Sorting , 2020, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[3] Julie G. Burel,et al. The challenge of distinguishing cell-cell complexes from singlet cells in non-imaging flow cytometry and single-cell sorting , 2020, bioRxiv.
[4] E. Solary,et al. Clinical, molecular, and prognostic correlates of number, type, and functional localization of TET2 mutations in chronic myelomonocytic leukemia (CMML)—a study of 1084 patients , 2019, Leukemia.
[5] A. Tefferi,et al. Chronic Myelomonocytic leukemia: 2020 update on diagnosis, risk stratification and management , 2019, American journal of hematology.
[6] T. D. de Gruijl,et al. Thrombomodulin-expressing monocytes are associated with low-risk features in myelodysplastic syndromes and dampen excessive immune activation , 2019, Haematologica.
[7] Julie G. Burel,et al. Circulating T cell-monocyte complexes are markers of immune perturbations , 2019, eLife.
[8] E. Solary,et al. A miR-150/TET3 pathway regulates the generation of mouse and human non-classical monocyte subset , 2018, Nature Communications.
[9] A. Harrington,et al. Immunophenotypes of Chronic Myelomonocytic Leukemia (CMML) Subtypes by Flow Cytometry: A Comparison of CMML-1 vs CMML-2, Myeloproliferative vs Dysplastic, De Novo vs Therapy-Related, and CMML-Specific Cytogenetic Risk Subtypes. , 2016, American journal of clinical pathology.
[10] Mario Cazzola,et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. , 2016, Blood.
[11] M. Stratton,et al. Mutation allele burden remains unchanged in chronic myelomonocytic leukaemia responding to hypomethylating agents , 2016, Nature Communications.
[12] E. Solary,et al. Characteristic repartition of monocyte subsets as a diagnostic signature of chronic myelomonocytic leukemia. , 2015, Blood.
[13] Piero Carninci,et al. Transcription and enhancer profiling in human monocyte subsets. , 2014, Blood.
[14] E. Solary,et al. Clonal architecture of chronic myelomonocytic leukemias. , 2013, Blood.
[15] Peter A. Jones,et al. Epigenetics in cancer. , 2010, Carcinogenesis.